Aptose Biosciences Inc.
APTOF
$1.60
-$0.06-3.61%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -19.29M | -21.12M | -21.33M | -25.43M | -35.80M |
| Total Depreciation and Amortization | 409.00K | 394.00K | 394.00K | 404.00K | 417.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 361.00K | 91.00K | 168.00K | 532.00K | 1.62M |
| Change in Net Operating Assets | -5.69M | -6.54M | -6.24M | -11.48M | -3.41M |
| Cash from Operations | -24.21M | -27.17M | -27.01M | -35.98M | -37.18M |
| Capital Expenditure | -5.00K | -5.00K | -5.00K | -5.00K | 0.00 |
| Sale of Property, Plant, and Equipment | 5.00K | 5.00K | 22.00K | 23.00K | 18.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 1.99M | 0.00 | 1.94M |
| Cash from Investing | 0.00 | 0.00 | 2.01M | 18.00K | 1.96M |
| Total Debt Issued | 20.35M | 22.60M | 20.00M | 20.00M | 10.00M |
| Total Debt Repaid | -100.00K | -100.00K | -- | -- | -- |
| Issuance of Common Stock | 829.00K | 837.00K | 5.77M | 16.79M | 17.63M |
| Repurchase of Common Stock | -3.35M | -3.35M | -3.35M | -3.35M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 156.00K | 156.00K | -21.00K | -21.00K | -167.00K |
| Cash from Financing | 17.88M | 20.14M | 22.40M | 33.41M | 27.46M |
| Foreign Exchange rate Adjustments | 0.00 | 0.00 | 1.00K | 0.00 | -1.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.33M | -7.03M | -2.60M | -2.55M | -7.76M |